Instrument Inactif

Gouvernance Tetraphase Pharmaceuticals, Inc.

US88165N2045

Produits pharmaceutiques

Comité Exécutif: Tetraphase Pharmaceuticals, Inc.

Dirigeant

Fonctions occupéesDepuis

Pavel Raifeld

42 ans

President

Stephen Basso

60 ans

Treasurer

Katherine Dorris

Corporate Secretary

Composition du Conseil d'Administration: Tetraphase Pharmaceuticals, Inc.

Administrateur

ComitésDepuis

Pavel Raifeld

42 ans

Director/Board Member

Anciens Dirigeants et Administrateurs: Tetraphase Pharmaceuticals, Inc.

Insider

Fonctions occupées

DepuisJusqu'au

Amy Quinlan

Comptroller/Controller/Auditor

01/01/2008

01/08/2020

Jeffrey Chodakewitz

Director/Board Member	17/06/2014	28/07/2020
Independent Dir/Board Member	17/06/2014	28/07/2020

Steven Boyd

Director/Board Member

31/01/2020

28/07/2020

Christopher Watt

Director of Finance/CFO

01/07/2015

28/07/2020

John Freund

Director/Board Member	23/10/2012	28/07/2020
Independent Dir/Board Member	23/10/2012	28/07/2020

Larry Edwards

Director/Board Member	01/08/2019	28/07/2020
Chief Executive Officer	01/08/2019	28/07/2020
Chief Operating Officer	01/03/2018	01/07/2019
Corporate Officer/Principal	01/01/2016	01/03/2018
President	01/08/2019	28/07/2020
Sales & Marketing	01/07/2015	01/01/2016

Leonard Patrick Gage

Chairman	01/12/2011	28/07/2020
Independent Dir/Board Member	01/12/2011	28/07/2020

Garen Bohlin

Director/Board Member	01/07/2010	28/07/2020
Independent Dir/Board Member	01/07/2010	28/07/2020

Maria D. Stahl

General Counsel	05/03/2015	28/07/2020
Corporate Officer/Principal	01/07/2019	28/07/2020

Nancy Wysenski

Director/Board Member	13/03/2014	28/07/2020
Independent Dir/Board Member	13/03/2014	28/07/2020

Illya Keith Maher

Director/Board Member

31/01/2020

28/07/2020

Kevin Tang

Director/Board Member

28/07/2020

Craig Johnson

Director/Board Member

28/07/2020

Gerri Henwood

Director/Board Member	15/04/2015	01/06/2020
Independent Dir/Board Member	15/04/2015	01/06/2020

Laura Nichols

Public Communications Contact

01/06/2015

01/03/2020

Thomas J. Ouellette

Sales & Marketing

01/01/2017

01/01/2020

Paula Rusu

Corporate Officer/Principal

01/01/2018

01/01/2020

Guy MacDonald

Director/Board Member	01/01/2008	01/08/2019
Chief Executive Officer	01/01/2008	01/08/2019
President	01/01/2008	01/08/2019

Jacques Dumas

Chief Tech/Sci/R&D Officer

01/07/2015

01/07/2019

Larry Tsai

Chief Tech/Sci/R&D Officer	02/01/2018	24/06/2019
Corporate Officer/Principal	01/01/2014	02/01/2018

Kamalam Unninayar

Director of Finance/CFO

16/10/2017

16/03/2018

Patrick Taylor Horn

Chief Tech/Sci/R&D Officer

25/01/2011

29/12/2017

John Mohr

Chief Tech/Sci/R&D Officer

01/07/2015

01/05/2016

David Lubner

Chief Operating Officer	07/07/2006	01/01/2010
Director of Finance/CFO	01/01/2010	01/01/2016

John Thompson

Chief Operating Officer

04/02/2014

31/12/2015

Steve Gullans

Director/Board Member	01/05/2010	15/04/2015
Independent Dir/Board Member	01/05/2010	15/04/2015

Paul J. Fanning

Human Resources Officer

01/01/2015

Maria S. Gawryl

General Counsel

01/03/2014

Douglas Cole

Director/Board Member	01/08/2006	18/10/2013
Independent Dir/Board Member	13/02/2013	18/10/2013

Lawrence Miller

Director/Board Member	18/01/2012	01/03/2013
Chairman	01/08/2006	18/01/2012
Independent Dir/Board Member	01/08/2006	01/03/2013

Karl D. Handelsman

Director/Board Member	16/04/2009	01/03/2013
Independent Dir/Board Member	01/08/2006	01/03/2013

Robert Mark Weisskoff

Director/Board Member	16/04/2009	-
Independent Dir/Board Member	01/07/2007	-

Eric M. Gordon

Director/Board Member

16/04/2009

23/10/2012

Joyce A. Sutcliffe

Corporate Officer/Principal

25/03/2010

Leland Webster

Corporate Officer/Principal

16/04/2009

Xiao-Yi Xiao

Corporate Officer/Principal

16/04/2009

Louis Plamondon

Chief Tech/Sci/R&D Officer	16/04/2009	11/09/2009
Corporate Officer/Principal	11/09/2009	-

Magnus Ronn

Corporate Officer/Principal

01/02/2011

Andrew G. Myers

Founder

07/07/2006

Jennifer Viera

Investor Relations Contact	-	-
Public Communications Contact	-	-

Erik Halvorsen

Director/Board Member

27/07/2010

Teri Dahlman

Investor Relations Contact

Joaquim Trias

Corporate Officer/Principal

Kerry Black

Corporate Officer/Principal

Paul A. Howard

Director/Board Member

Michael Gray

Director of Finance/CFO

Paul Reider

Corporate Officer/Principal

Joseph Solomkin

Corporate Officer/Principal

Distribution de l'Âge des Dirigeants

Parité Homme Femme

Homme	2
Femme	1

Dont comité exécutif

Homme	2
Femme	1

Dont Administrateurs

Homme	1
Femme	0

Tetraphase Pharmaceuticals, Inc. est une société biopharmaceutique au stade clinique. La société utilise sa technologie chimique pour créer des antibiotiques pour les infections multirésistantes. La société développe son principal produit candidat, l'éravacycline, un dérivé entièrement synthétique de la tétracycline, en tant qu'antibiotique intraveineux (IV) et oral à spectre large pour une utilisation en tant que monothérapie empirique de première ligne pour le traitement des infections multirésistantes, y compris les infections gram-négatives multirésistantes. La société développe également le TP-6076 pour les infections gram-négatives multirésistantes. L'éravacycline est un antibiotique de la famille des fluorocyclines. La société mène un programme clinique mondial de phase III pour l'éravacycline appelé IGNITE (Investigating Gram-Negative Infections Treated with Eravacycline). Le TP-271 est une fluorocycline entièrement synthétique en cours de développement pour les maladies respiratoires causées par des agents pathogènes biologiques chez des volontaires sains.

Employés

Secteur

Produits pharmaceutiques

Plus d'informations sur la société